ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Glaukos Corporation clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 67 studies whose lead sponsor is Glaukos Corporation. 14 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 30, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Glaukos with Huons Global and Ache Laboratorios Farmaceuticos →

Pipeline: 5 programs

Each counted once: 5 with a study Glaukos Corporation leads registered in the last two years.

  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Glaukos Corporation’s own registered studies; Glaukos Corporation’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Glaukos Corporation’s studies test, most open studies first — 6 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

4 of Glaukos Corporation’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. 1A
  7. 1M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add all 4 to your calendar (.ics) → With an account.

All 67 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1421%
  • Under way, not recruiting34%
  • Completed3958%
  • Stopped early710%Terminated 6 · Withdrawn 1
  • Status unknown or other46%

Phase

  • Phase 415
  • Phase 314
  • Phase 213
  • Phase 12

Where

  • United States39
  • Armenia17
  • Germany8
  • Spain7
  • Austria4
  • Turkey4

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 713
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 326

By the year each study started; 5 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Glaukos Corporation.

  • Glaukos Corporation
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    67 studies

Focus areas

Conditions Glaukos Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 67. Browse all 67 →